Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders
Author:
Affiliation:
1. Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm9012906
Reference64 articles.
1. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis
2. p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis
3. How antirheumatic drugs protect joints from damage in rheumatoid arthritis
Cited by 151 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. NJK14047 inhibition of p38 MAPK ameliorates inflammatory immune diseases by suppressing T cell differentiation;International Immunopharmacology;2024-03
2. Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i);Pharmaceuticals;2023-09-12
3. Senescence in cancer: Advances in detection and treatment modalities;Biochemical Pharmacology;2023-09
4. Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry;Pharmaceuticals;2023-07-12
5. EMERGING SMALL-MOLECULE THERAPEUTICS FOR DILATED CARDIOMYOPATHY;2022 Medicinal Chemistry Reviews;2022-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3